Daiichi Sankyo Buys Its First U.S. Packaging and Manufacturing Plant
Executive Summary
Daiichi Sankyo Inc. has purchased a plant in Bethlehem Township, Pa., that will package the seven products the company currently markets in the U.S. The facility may also eventually manufacture Daiichi products.
You may also be interested in...
Ranbaxy Enhances Facility Operations But Deadlock On FDA Action Remains
MUMBAI - Daiichi Sankyo's India affiliate Ranbaxy has put in place enhanced systems and processes to upgrade its manufacturing facilities and R&D centers to respond to U.S. FDA punitive actions related to alleged lapses in good manufacturing practices at Ranbaxy's two India-based sites
A Visual Guide To How FDA Can Manage The Pandemic
Our infographic illustrates the recommendations in FDA’s COVID-19 pandemic recovery and preparedness plan, ranging from strengthening the EUA process to managing the backlog of pending inspections.
Permanent Vaccine Facility Should Be On Standby For Future Pandemics, Moncef Slaoui Says
Operation Warp Speed confirmed the necessity of having a facility on hand to develop and manufacture a vaccine for the next crisis, the outgoing advisor says.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: